Academic Fellow Rachel E. Sachs featured in Regulatory Reconnaissance
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. Want to read Recon as soon as it's posted? Follow @Michael_Mezher, @Zachary Brennan and @RAPSorg on Twitter.
In Focus: US
-
Samsung Targets US Drug Market With Remicade Biosimilar (WSJ-$) (Reuters) (Press)
-
Republican Senators Lobby FDA Ahead of Decision on Sarepta's DMD Drug (Focus) (STAT)
-
Our Current Pharmaceutical Payment System Isn't Neutral (Harvard Bill of Health)
Check out Rachel's full post at Petrie-Flom's blog Bill of Health!
Read the Full Briefing from Regulatory Affairs!
Tags
health care finance health law policy pharmaceuticals rachel sachs regulation